The Pharma Letter5h
FDA approves new injectable version of Opdivo
The US Food and Drug Administration (FDA) on Friday approved nivolumab and hyaluronidase-nvhy, under the trade name Opdivo ...
The Pharma Letter19h
Synergy Pharmaceuticals
USA-based biopharma group Synergy Pharmaceuticals (Nasdaq: SGYP) is a biopharmaceutical company dedicated to developing new drugs to treat patients with gastrointestinal disorders and diseases.
The Pharma Letter1d
AusperBio raises $73 million to advance hepatitis B therapy
AusperBio raises $73 million in series B funding to advance Phase II trials of AHB-137, its antisense oligonucleotide therapy ...
The Pharma Letter1d
Mankind Pharma and Innovent partner for sintilimab
Mumbai, India-based Mankind Pharma has entered into a partnership with China’s Innovent Biologics for exclusively licensing ...
The Pharma Letter1d
FDA label changes for transmucosal buprenorphine products
The US Food and Drug Administration (FDA) has issued the Federal Register notice, Modifications to Labeling of ...
The Pharma Letter4d
Viatris faces FDA import restrictions at Indian facility
Viatris faces US FDA regulatory action on its Indore, India facility, with a warning letter and import alert restricting 11 ...